“Efficacy and Safety of CD19-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy in Refractory Systemic Lupus Erythematosus: A Systematic Review of Clinical Outcomes and B-Cell Depletion Kinetics”. Archives of The Medicine and Case Reports, vol. 7, no. 1, Dec. 2025, pp. 1-18, https://doi.org/10.37275/amcr.v7i1.831.